Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal.

  • Authors : Svensson MND; Department of Medicine, Altman Clinical and Translational Research Institute, University of California, San Diego, La Jolla, CA 92093, USA.; Division of Cellular Biology, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid* ; Synoviocytes*/Synoviocytes*/Synoviocytes*/metabolism

  • Source: Science advances [Sci Adv] 2020 Jun 26; Vol. 6 (26), pp. eaba4353. Date of Electronic Publication: 2020 Jun 26 (Print Publication: 2020).Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication

Record details

×
Academic Journal

Epilepsy's next frontier.

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Drug Resistant Epilepsy/Drug Resistant Epilepsy/Drug Resistant Epilepsy/*drug therapy ; Drug Resistant Epilepsy/Drug Resistant Epilepsy/Drug Resistant Epilepsy/*etiology

  • Source: Science (New York, N.Y.) [Science] 2019 Dec 13; Vol. 366 (6471), pp. 1300-1304.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Report

Clinical trials. Gene transfer an unlikely contributor to patient's death.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*adverse effects ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*adverse effects ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*therapy

  • Source: Science (New York, N.Y.) [Science] 2007 Dec 07; Vol. 318 (5856), pp. 1535.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Periodical

Patents. Antibody drug dispute ends in $255 million cash payout.

Subjects: Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Patents as Topic*

  • Source: Science (New York, N.Y.) [Science] 2005 Nov 04; Vol. 310 (5749), pp. 761.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
Academic Journal

Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.

  • Authors : Doody KM; Division of Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.; Stanford SM

Subjects: Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*pharmacology ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*prevention & control ; Chondroitin Sulfate Proteoglycans/Chondroitin Sulfate Proteoglycans/Chondroitin Sulfate Proteoglycans/*metabolism

  • Source: Science translational medicine [Sci Transl Med] 2015 May 20; Vol. 7 (288), pp. 288ra76.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication

Record details

×
Periodical

Autoimmune diseases. The B cell slayer.

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

  • Source: Science (New York, N.Y.) [Science] 2007 Nov 23; Vol. 318 (5854), pp. 1232-3.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication

Record details

×
  • 1-10 of  24 results for ""Antirheumatic Agents""